Better diagnosis of pneumocystis in patients with weak immune systems
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests a new way to diagnose pneumocystis, a lung infection that can affect people with weakened immune systems. It may help find the infection faster and more accurately using samples taken from your lungs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older).
- Your doctor suspects you have a lung infection called pneumocystis.
- You need a bronchoscopy (a tube into your lungs) to collect fluid or sputum for testing.
- You or your family member agree to let you be in the study.
- You have not received treatment for pneumocystis for more than 72 hours.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different second-line antibiotics for treating Pneumocystis pneumonia (a serious lung infection) in people with weakened immune systems. It aims to find the best alternative when the standard treatment cannot be used.
This trial tests a new inhaled medicine (caspofungin) added to standard treatment for Pneumocystis pneumonia, a serious lung infection. It may help fight the infection more effectively while you are already receiving oxygen and standard antibiotics.
This study looks at samples from people who have a lung infection called PCP (a type of pneumonia). The goal is to learn more about the germ that causes it, which might lead to better treatments in the future.
This study compares a newer, faster lab test (BioFire FilmArray) to standard testing for identifying the germs causing lung infections in hospitalized patients. The goal is to see if the faster test helps doctors choose better antibiotics more quickly.
This research study examines proteins in fluid collected from your lungs during a breathing tube procedure (bronchoscopy) to better understand pneumonia. By studying these proteins, researchers hope to improve how doctors diagnose and treat lung infections.
This trial tests a faster way to detect Pseudomonas aeruginosa, a common cause of lung infections, using special imaging. It aims to see if this rapid test can help doctors track how well treatment is working.
Hear when a new Pneumocystis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.